For Alex Tempany, managing type 1 diabetes has always been a balancing act — between designing jewellery collections, attending fashion events, and raising two young daughters, while also keeping her health in check. For most of her life, that meant bulky devices, multiple daily injections, and constant finger-prick testing. The reality of diabetes was always visible, always demanding attention, and sometimes felt like it was running her schedule instead of the other way around.
This year, that changed. Alex is among the first Australians to use the Libre 3 Plus, the world’s smallest continuous glucose monitor. Roughly the size of a $2 coin, it sits discreetly on the upper arm and sends real-time glucose readings directly to her smartphone. Suddenly, monitoring her health doesn’t interrupt her day — it integrates seamlessly, letting her focus on her work, her family, and her life without constant reminders of her condition.
What makes the Libre 3 Plus remarkable isn’t just its small size. The device continuously tracks glucose levels for up to 15 days, sending instant updates straight to a smartphone app. This real-time monitoring removes the need for routine finger-prick tests, one of the most intrusive parts of living with diabetes. Users can see where their glucose levels are at any moment, giving them freedom and peace of mind in everyday life.
Libre 3 Plus
The sensor also integrates with compatible insulin pumps, such as the mylife YpsoPump, enabling automated insulin delivery. By linking directly with the pump, the CGM can help adjust insulin doses throughout the day without manual intervention. This combination reduces errors, eases decision-making, and allows users to maintain more consistent glucose levels — a practical benefit that translates into less mental load and more confidence.
Comfort and discretion were key design priorities. The sensor sits flat against the skin, hidden under clothing, and doesn’t interfere with daily routines. For people who rely on CGMs, this near-invisibility is a major upgrade from previous models that were often bulky or difficult to conceal. A device this small and unobtrusive can make a huge difference in confidence, allowing users to focus on life rather than constantly adjusting for technology.
The accompanying smartphone app brings another layer of clarity. Glucose trends, alerts, and patterns are displayed in a clean, easy-to-read format, giving users actionable insights into how meals, exercise, stress, and daily activity affect their glucose. For many, this real-time visibility is transformative: it’s not just about insulin delivery, but about understanding the body and making informed choices.
Living with type 1 diabetes
The Libre 3 Plus also reflects a broader evolution in diabetes care toward connected, intuitive technology. When sensors and pumps communicate seamlessly, management becomes smoother and less intrusive. Older systems often required juggling multiple devices, manual inputs, and constant monitoring, creating unnecessary stress. Now, connected CGM and insulin pump systems simplify the process, making everyday management feel more natural.
For Australians living with type 1 diabetes, the arrival of the Libre 3 Plus is a meaningful shift. It combines small, discreet design with smart technology and automated care, empowering users to manage their condition without letting it dominate their lives. Beyond its size, it delivers control, confidence, and freedom — letting people focus on work, family, and the things they love.
In a device roughly the size of a coin, there’s a quiet revolution happening. For Alex, and thousands of others, it’s a chance to reclaim time, reduce stress, and move through life without constant interruptions. Small in size, but enormous in impact, the Libre 3 Plus is a reminder that thoughtful design and connected technology can truly transform how we live with chronic conditions.
